Iloprost improves endothelial barrier function in lipopolysaccharide- induced lung injury

European Respiratory Journal

Volumn 41, Issue 1, 2013, Pages 165-176

  Birukova, Anna A ^a   Wu, Tinghuai ^a   Tian, Yufeng ^a   Meliton, Angelo ^a   Sarich, Nicolene ^a   Tian, Xinyong ^a   Alan, Leff ^a   Birukov, Konstantin G ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cytoskeleton; Endothelium; Inflammation; Lung; Permeability

Indexed keywords

8 BROMO CYCLIC AMP; EVANS BLUE; ILOPROST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; RAC PROTEIN; RHO FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CELL DISRUPTION; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE MIGRATION; LUNG INJURY; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; ENDOTHELIUM; ILOPROST; LIPOPOLYSACCHARIDES; LUNG; LUNG INJURY; MICE; MICE, INBRED C57BL; NEUROPEPTIDES; RAC GTP-BINDING PROTEINS;

EID: 84872195537     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00148311     Document Type: Article

References (47)

1. Ricard JD, Dreyfuss D, Saumon G. Ventilator-induced lung injury. Eur Respir J 2003; 22: Suppl. 42, 2s-9s.
2. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003; 167: 1027-1035.
3. Goodman RB, Pugin J, Lee JS, et al. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003; 14: 523-535.
4. Dreyfuss D, Ricard JD. Acute lung injury and bacterial infection. Clin Chest Med 2005; 26: 105-112.
5. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322-329.
6. Matthay MA, Robriquet L, Fang X. Alveolar epithelium: role in lung fluid balance and acute lung injury. Proc Am Thorac Soc 2005; 2: 206-213.
7. Howard LS, Morrell NW. New therapeutic agents for pulmonary vascular disease. Paediatr Respir Rev 2005; 6: 285-291.
8. 2, and its mechanisms. Prostaglandins 1997; 53: 279-289.
9. 2 promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Exp Cell Res 2007; 313: 2504-2520.
10. Birukova AA, Fu P, Xing J, et al. Rap1 mediates protective effects of iloprost against ventilator induced lung injury. J Appl Physiol 2009; 107: 1900-1910.
11. Yuan SY. Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol 2002; 39: 213-223.
12. Bos JL. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 2006; 31: 680-686.
13. Fukuhara S, Sakurai A, Sano H, et al. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 2005; 25: 136-146.
14. Kooistra MR, Corada M, Dejana E, et al. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 2005; 579: 4966-4972.
15. Birukova AA, Burdette D, Moldobaeva N, et al. Rac GTPase is a hub for protein kinase A and Epac signaling in endothelial barrier protection by cAMP. Microvasc Res 2010; 79: 128-138.
16. Birukov KG, Bochkov VN, BirukovaAA, et al. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. Circ Res 2004; 95: 892-901.
17. Duan Y, Learoyd J, Meliton AY, et al. Inhibition of Pyk2 blocks airway inflammation and hyperresponsiveness in a mouse model of asthma. Am J Respir Cell Mol Biol 2010; 42: 491-497.
18. Birukova AA, Fu P, Xing J, et al. Mechanotransduction by GEF-H1 as a novel mechanism of ventilator-induced vascular endothelial permeability. Am J Physiol Lung Cell Mol Physiol 2010; 298: L837-L848.
19. Potter MD, Barbero S, Cheresh DA. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and β-catenin and maintains the cellular mesenchymal state. J Biol Chem 2005; 280: 31906-31912.
20. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008; 121: 2115-2122.
21. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008; 42: 145-151.
22. Bogatcheva NV, Dudek SM, Garcia JG, et al. Mitogen-activated protein kinases in endothelial pathophysiology. J Investig Med 2003; 51: 341-352.
23. Suchner U, Katz DP, Furst P, et al. Effects of intravenous fat emulsions on lung function in patients with acute respiratory distress syndrome or sepsis. Crit Care Med 2001; 29: 1569-1574.
24. Arons MM, Wheeler AP, Bernard GR, et al. Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med 1999; 27: 699-707.
25. Lassus P, Viinikka L, Ylikorkala O, et al. Pulmonary prostacyclin is associated with less severe respiratory distress in preterm infants. Early Hum Dev 2002; 67: 11-18.
26. Hucklenbruch C, Hinder F, Berger C, et al. Effects of inhaled aerosolized iloprost and inhaled NO on pulmonary circulation and edema formation in ovine lung injury. Shock 2008; 30: 75-80.
27. Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997; 336: 912-918.
28. Dembinski R, Brackhahn W, Henzler D, et al. Cardiopulmonary effects of iloprost in experimental acute lung injury. Eur Respir J 2005; 25: 81-87.
29. Maitra U, Singh N, Gan L, et al. IRAK-1 contributes to lipopolysaccharide-induced reactive oxygen species generation in macrophages by inducing NOX-1 transcription and Rac1 activation and suppressing the expression of antioxidative enzymes. J Biol Chem 2009; 284: 35403-35411.
30. Miletic AV, Graham DB, Montgrain V, et al. Vav proteins control MyD88-dependent oxidative burst. Blood 2007; 109: 3360-3368.
31. Fu P, Birukova AA, Xing J, et al. Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. Eur Respir J 2009; 33: 612-624.
32. Birukova AA, Alekseeva E, Mikaelyan A, et al. HGF attenuates thrombin-induced endothelial permeability by Tiam1-mediated activation of the Rac pathway and by Tiam1/Rac-dependent inhibition of the Rho pathway. FASEB J 2007; 21: 2776-2786.
33. Garcia JG, Liu F, Verin AD, et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 2001; 108: 689-701.
34. Singleton PA, Dudek SM, Ma SF, et al. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem 2006; 281: 34381-34393.
35. Roberts AW, Kim C, Zhen L, et al. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 1999; 10: 183-196.
36. Gu Y, Filippi MD, Cancelas JA, et al. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 2003; 302: 445-449.
37. Glogauer M, Marchal CC, Zhu F, et al. Rac1 deletion in mouse neutrophils has selective effects on neutrophil functions. J Immunol 2003; 170: 5652-5657.
38. Maniatis NA, Kotanidou A, Catravas JD, et al. Endothelial pathomechanisms in acute lung injury. Vascul Pharmacol 2008; 49: 119-133.
39. Malliri A, van Es S, Huveneers S, et al. The Rac exchange factor Tiam1 is required for the establishment and maintenance of cadherin-based adhesions. J Biol Chem 2004; 279: 30092-30098.
40. Birukova AA, Malyukova I, Mikaelyan A, et al. Tiam1 and bPIX mediate Rac-dependent endothelial barrier protective response to oxidized phospholipids. J Cell Physiol 2007; 211: 608-617.
41. Lawson CD, Donald S, Anderson KE, et al. P-Rex1 and Vav1 cooperate in the regulation of formyl-methionyl-leucyl-phenylalanine-dependent neutrophil responses. J Immunol 2011; 186: 1467-1476.
42. Perez-Moreno M, Davis MA, Wong E, et al. p120-catenin mediates inflammatory responses in the skin. Cell 2006; 124: 631-644.
43. Perona R, Montaner S, Saniger L, et al. Activation of the nuclear factor-κB by Rho, CDC42, and Rac-1 proteins. Genes Dev 1997; 11: 463-475.
44. Xiaolu D, Jing P, Fang H, et al. Role of p115RhoGEF in lipopolysaccharide-induced mouse brain microvascular endothelial barrier dysfunction. Brain Res 2011; 1387: 1-7.
45. Matoba K, Kawanami D, Ishizawa S, et al. Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells. Biochem Biophys Res Commun 2010; 402: 725-730.
46. Shatanawi A, Romero MJ, Iddings JA, et al. Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway. Am J Physiol Cell Physiol 2011; 300: C1181-C1192.
47. Cariolato L, Cavin S, Diviani D. A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in alpha1-adrenergic receptor-induced p38 activation. J Biol Chem 2011; 286: 7925-7937.